Rifampin
NDC Package 0069-0141-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Rifampin is a medication a rifamycin antibiotic used to prevent and treat tuberculosis and other infections. Marketed by Pfizer Laboratories Div Pfizer Inc, this product is identified by NDC 0069-0141 and is authorized under FDA application ANDA065421.

Identification & Billing

NDC Package Code
0069-0141-01
Package Description
10 mL in 1 VIAL
Product Code
0069-0141
11-Digit Billing Format
00069014101

Clinical Specifications

Proprietary Name
Rifampin
Dosage Form
-
Usage Information
This medication is a rifamycin antibiotic used to prevent and treat tuberculosis and other infections. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

Regulatory & Marketing

Labeler Name
Pfizer Laboratories Div Pfizer Inc
FDA Application #
ANDA065421
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
05-10-2011
End Marketing Date
12-31-2017
Listing Expiration
12-31-2017
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0069-0141-01 identifies a specific commercial package of 10 ml in 1 vial of Rifampin, labeled by Pfizer Laboratories Div Pfizer Inc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Pfizer Laboratories Div Pfizer Inc on May 10, 2011. The current certification is valid through December 31, 2017.

What are the primary indications for this medication?

This medication is a rifamycin antibiotic used to prevent and treat tuberculosis and other infections. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

How is this Pfizer Laboratories Div Pfizer Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00069014101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0069-0141-01
11-Digit CMS (5-4-2)
00069-0141-01

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.